RhumbLine Advisers’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-239,936
Closed -$20.4M 3067
2020
Q3
$20.4M Sell
239,936
-10,589
-4% -$900K 0.03% 468
2020
Q2
$8.88M Sell
250,525
-33,597
-12% -$1.19M 0.01% 843
2020
Q1
$3.83M Buy
284,122
+27,123
+11% +$366K 0.01% 1186
2019
Q4
$5.44M Buy
256,999
+8,876
+4% +$188K 0.01% 1206
2019
Q3
$3.29M Buy
248,123
+3,138
+1% +$41.6K 0.01% 1429
2019
Q2
$3.4M Buy
244,985
+44,052
+22% +$611K 0.01% 1415
2019
Q1
$3.86M Buy
200,933
+5,559
+3% +$107K 0.01% 1330
2018
Q4
$2.79M Buy
195,374
+64,659
+49% +$923K 0.01% 1455
2018
Q3
$2.72M Sell
130,715
-2,354
-2% -$49K 0.01% 1493
2018
Q2
$3.15M Buy
133,069
+27,998
+27% +$663K 0.01% 1407
2018
Q1
$1.54M Sell
105,071
-2,280
-2% -$33.3K ﹤0.01% 1746
2017
Q4
$1.74M Sell
107,351
-17,375
-14% -$281K ﹤0.01% 1701
2017
Q3
$1.74M Buy
124,726
+1,235
+1% +$17.3K ﹤0.01% 1693
2017
Q2
$1.09M Buy
123,491
+12,375
+11% +$109K ﹤0.01% 1912
2017
Q1
$719K Buy
111,116
+4,107
+4% +$26.6K ﹤0.01% 2083
2016
Q4
$393K Buy
107,009
+9,991
+10% +$36.7K ﹤0.01% 2349
2016
Q3
$315K Sell
97,018
-18,930
-16% -$61.5K ﹤0.01% 2460
2016
Q2
$269K Buy
115,948
+13,313
+13% +$30.9K ﹤0.01% 2591
2016
Q1
$257K Buy
102,635
+2,200
+2% +$5.51K ﹤0.01% 2611
2015
Q4
$308K Buy
100,435
+795
+0.8% +$2.44K ﹤0.01% 2564
2015
Q3
$171K Buy
99,640
+12,192
+14% +$20.9K ﹤0.01% 2841
2015
Q2
$355K Buy
87,448
+1,805
+2% +$7.33K ﹤0.01% 2543
2015
Q1
$328K Buy
85,643
+14,700
+21% +$56.3K ﹤0.01% 2560
2014
Q4
$341K Buy
70,943
+2,600
+4% +$12.5K ﹤0.01% 2509
2014
Q3
$254K Hold
68,343
﹤0.01% 2618
2014
Q2
$249K Buy
68,343
+4,288
+7% +$15.6K ﹤0.01% 2711
2014
Q1
$270K Sell
64,055
-3,580
-5% -$15.1K ﹤0.01% 2602
2013
Q4
$311K Sell
67,635
-1,600
-2% -$7.36K ﹤0.01% 2562
2013
Q3
$429K Buy
69,235
+531
+0.8% +$3.29K ﹤0.01% 2314
2013
Q2
$374K Buy
+68,704
New +$374K ﹤0.01% 2485